{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:05:42Z","timestamp":1791140742934,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T00:00:00Z","timestamp":1419897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T00:00:00Z","timestamp":1419897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s12013-014-0431-5","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T11:53:53Z","timestamp":1419854033000},"page":"165-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Clinical Research of Serum VEGF, TGF-\u03b21, and Endostatin in Non-small Cell Lung Cancer"],"prefix":"10.1007","volume":"72","author":[{"given":"Shu-Guang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang-Hu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Suo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,30]]},"reference":[{"issue":"7","key":"431_CR1","doi-asserted-by":"publisher","first-page":"e103440","DOI":"10.1371\/journal.pone.0103440","volume":"9","author":"E Zhang","year":"2014","unstructured":"Zhang, E., et al. (2014). Roles of PI3K\/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1alpha, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells. PLoS One,\n                  9(7), e103440.","journal-title":"PLoS One"},{"issue":"7","key":"431_CR2","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1113\/expphysiol.2014.078527","volume":"99","author":"H Xia","year":"2014","unstructured":"Xia, H., et al. (2014). Aquaporin 3 knockdown suppresses tumour growth and angiogenesis in experimental non-small cell lung cancer. Experimental Physiology,\n                  99(7), 974\u2013984.","journal-title":"Experimental Physiology"},{"issue":"5","key":"431_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.bbadis.2014.01.011","volume":"1842","author":"MC Cathcart","year":"2014","unstructured":"Cathcart, M. C., et al. (2014). Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer. Biochimica et Biophysica Acta,\n                  1842(5), 747\u2013755.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"3","key":"431_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0254-6272(13)60169-7","volume":"33","author":"J Liu","year":"2013","unstructured":"Liu, J., & Liu, Y. (2013). Influence of erbanxiao solution on inhibiting angiogenesis in stasis toxin stagnation of non-small cell lung cancer. Journal of Traditional Chinese Medicine,\n                  33(3), 303\u2013306.","journal-title":"Journal of Traditional Chinese Medicine"},{"issue":"3","key":"431_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00280-012-1923-x","volume":"70","author":"X Li","year":"2012","unstructured":"Li, X., et al. (2012). Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways. Cancer Chemotherapy and Pharmacology,\n                  70(3), 425\u2013437.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"6","key":"431_CR6","first-page":"1049","volume":"13","author":"A Yoshimoto","year":"2005","unstructured":"Yoshimoto, A., et al. (2005). Characterization of the prostaglandin biosynthetic pathway in non-small cell lung cancer: A comparison with small cell lung cancer and correlation with angiogenesis, angiogenic factors and metastases. Oncology Reports,\n                  13(6), 1049\u20131057.","journal-title":"Oncology Reports"},{"key":"431_CR7","doi-asserted-by":"publisher","unstructured":"Wang, S. et al. (2014). The effect of Lfcin-B on non-small cell lung cancer H460 cells is mediated by inhibiting VEGF expression and inducing apoptosis. Archives of Pharmacal Research. doi:\n                    10.1007\/s12272-014-0373-x\n                    \n                  .","DOI":"10.1007\/s12272-014-0373-x"},{"key":"431_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cca.2013.10.002","volume":"427","author":"H Jiang","year":"2014","unstructured":"Jiang, H., Shao, W., & Zhao, W. (2014). VEGF-C in non-small cell lung cancer: meta-analysis. Clinica Chimica Acta,\n                  427, 94\u201399.","journal-title":"Clinica Chimica Acta"},{"issue":"47","key":"431_CR9","doi-asserted-by":"publisher","first-page":"39967","DOI":"10.1074\/jbc.M112.397042","volume":"287","author":"K Deacon","year":"2012","unstructured":"Deacon, K., et al. (2012). Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer. Journal of Biological Chemistry,\n                  287(47), 39967\u201339981.","journal-title":"Journal of Biological Chemistry"},{"issue":"11","key":"431_CR10","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1038\/labinvest.3780177","volume":"80","author":"A Yuan","year":"2000","unstructured":"Yuan, A., et al. (2000). Quantification of VEGF mRNA expression in non-small cell lung cancer using a real-time quantitative reverse transcription-PCR assay and a comparison with quantitative competitive reverse transcription-PCR. Laboratory Investigation,\n                  80(11), 1671\u20131680.","journal-title":"Laboratory Investigation"},{"issue":"5","key":"431_CR11","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1007\/s13277-014-1628-3","volume":"35","author":"ZZ Fu","year":"2014","unstructured":"Fu, Z. Z., et al. (2014). Relationship of serum levels of VEGF and TGF-beta1 with radiosensitivity of elderly patients with unresectable non-small cell lung cancer. Tumour Biology,\n                  35(5), 4785\u20134789.","journal-title":"Tumour Biology"},{"issue":"3","key":"431_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3109\/07357907.2010.543208","volume":"29","author":"S Kumar","year":"2011","unstructured":"Kumar, S., et al. (2011). Efficacy of plasma TGF-beta1 level in predicting therapeutic efficacy and prognosis in patients with advanced non-small cell lung cancer. Cancer Investigation,\n                  29(3), 202\u2013207.","journal-title":"Cancer Investigation"},{"issue":"5","key":"431_CR13","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ijrobp.2008.10.065","volume":"74","author":"L Zhao","year":"2009","unstructured":"Zhao, L., et al. (2009). Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: A combined analysis from Beijing and Michigan. International Journal of Radiation Oncology Biology Physics,\n                  74(5), 1385\u20131390.","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"431_CR14","doi-asserted-by":"publisher","unstructured":"Naumnik, W. et al. (2014). Endostatin and cathepsin-V in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Advances in Experimental Medicine and Biology. doi:\n                    10.1007\/5584_2014_26\n                    \n                  .","DOI":"10.1007\/5584_2014_26"},{"issue":"8","key":"431_CR15","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/bjc.2014.456","volume":"111","author":"T Kantola","year":"2014","unstructured":"Kantola, T., et al. (2014). Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers. British Journal of Cancer,\n                  111(8), 1605\u20131613.","journal-title":"British Journal of Cancer"},{"issue":"6","key":"431_CR16","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1161\/HYPERTENSIONAHA.113.02250","volume":"62","author":"AC Carlsson","year":"2013","unstructured":"Carlsson, A. C., et al. (2013). Association between circulating endostatin, hypertension duration, and hypertensive target-organ damage. Hypertension,\n                  62(6), 1146\u20131151.","journal-title":"Hypertension"},{"issue":"3","key":"431_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3109\/02713683.2012.745880","volume":"38","author":"AM Roszkowska","year":"2013","unstructured":"Roszkowska, A. M., et al. (2013). Contact lens wearing and chronic cigarette smoking positively correlate with TGF-beta1 and VEGF tear levels and impaired corneal wound healing after photorefractive keratectomy. Current Eye Research,\n                  38(3), 335\u2013341.","journal-title":"Current Eye Research"},{"issue":"5","key":"431_CR18","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/1541-7786.MCR-11-0507","volume":"10","author":"G Ferrari","year":"2012","unstructured":"Ferrari, G., et al. (2012). TGF-beta1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38beta to proapoptotic p38alpha. Molecular Cancer Research,\n                  10(5), 605\u2013614.","journal-title":"Molecular Cancer Research"},{"issue":"2","key":"431_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/MPG.0b013e3182144c74","volume":"53","author":"A Wedrychowicz","year":"2011","unstructured":"Wedrychowicz, A., et al. (2011). Serum concentrations of VEGF and TGF-beta1 during exclusive enteral nutrition in IBD. Journal of Pediatric Gastroenterology and Nutrition,\n                  53(2), 150\u2013155.","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"1","key":"431_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.biopha.2009.03.003","volume":"64","author":"FA Araujo","year":"2010","unstructured":"Araujo, F. A., et al. (2010). Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1. Biomedicine & Pharmacotherapy,\n                  64(1), 29\u201334.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"431_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/jcp.21706","volume":"219","author":"G Ferrari","year":"2009","unstructured":"Ferrari, G., et al. (2009). Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. Journal of Cellular Physiology,\n                  219(2), 449\u2013458.","journal-title":"Journal of Cellular Physiology"},{"issue":"4","key":"431_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4143\/crt.2013.45.4.325","volume":"45","author":"JW Kim","year":"2013","unstructured":"Kim, J. W., et al. (2013). Clinical implications of VEGF, TGF-beta1, and IL-1beta in patients with advanced non-small cell lung cancer. Cancer Research Treat,\n                  45(4), 325\u2013333.","journal-title":"Cancer Research Treat"},{"issue":"9","key":"431_CR23","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.ejso.2014.05.014","volume":"40","author":"Y Hu","year":"2014","unstructured":"Hu, Y., et al. (2014). Imbalance between vascular endothelial growth factor and endostatin correlates with the prognosis of operable non-small cell lung cancer. European Journal of Surgical Oncology,\n                  40(9), 1136\u20131142.","journal-title":"European Journal of Surgical Oncology"},{"issue":"6","key":"431_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4149\/neo_2013_079","volume":"60","author":"YB Li","year":"2013","unstructured":"Li, Y. B., et al. (2013). Radiosensitization of breast cancer cells by TRAIL-endostatin-targeting gene therapy. Neoplasma,\n                  60(6), 613\u2013619.","journal-title":"Neoplasma"},{"issue":"12","key":"431_CR25","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1097\/JTO.0b013e3182725fe0","volume":"7","author":"TQ Chu","year":"2012","unstructured":"Chu, T. Q., et al. (2012). Can determination of circulating endothelial cells and serum caspase-cleaved CK18 predict for response and survival in patients with advanced non-small-cell lung cancer receiving endostatin and paclitaxel-carboplatin chemotherapy? a retrospective study. Journal of Thoracic Oncology,\n                  7(12), 1781\u20131789.","journal-title":"Journal of Thoracic Oncology"},{"issue":"1","key":"431_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/gyno.1999.5496","volume":"74","author":"L Hefler","year":"1999","unstructured":"Hefler, L., et al. (1999). Serum concentrations of endostatin in patients with vulvar cancer. Gynecologic Oncology,\n                  74(1), 151\u2013152.","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"431_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0169-5002(01)00285-9","volume":"35","author":"M Suzuki","year":"2002","unstructured":"Suzuki, M., et al. (2002). Serum endostatin correlates with progression and prognosis of non-small cell lung cancer. Lung Cancer,\n                  35(1), 29\u201334.","journal-title":"Lung Cancer"},{"issue":"2","key":"431_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/ng1001-117","volume":"29","author":"R Derynck","year":"2001","unstructured":"Derynck, R., Akhurst, R. J., & Balmain, A. (2001). TGF-beta signaling in tumor suppression and cancer progression. Nature Genetics,\n                  29(2), 117\u2013129.","journal-title":"Nature Genetics"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-0431-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12013-014-0431-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-0431-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-0431-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T18:41:07Z","timestamp":1602268867000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12013-014-0431-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,30]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["431"],"URL":"https:\/\/doi.org\/10.1007\/s12013-014-0431-5","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,30]]},"assertion":[{"value":"30 December 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}